OSTERWEIS CAPITAL MANAGEMENT INC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
OSTERWEIS CAPITAL MANAGEMENT INC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2021$4,574,000
-28.6%
144,461
+4.7%
0.25%
-34.8%
Q4 2020$6,402,000
+23.3%
137,981
-12.5%
0.38%
+9.1%
Q3 2020$5,193,000
+40.8%
157,751
+17.4%
0.35%
+31.1%
Q2 2020$3,689,000
+4.1%
134,391
+13.5%
0.27%
-7.3%
Q1 2020$3,545,000
-7.4%
118,421
-14.4%
0.29%
+8.7%
Q4 2019$3,829,000
+39.9%
138,325
-8.0%
0.26%
+32.5%
Q3 2019$2,737,000
-23.2%
150,410
+3.5%
0.20%
-20.6%
Q2 2019$3,565,000
-3.6%
145,380
-62.6%
0.25%
+9.1%
Q1 2019$3,699,000
-27.6%
388,995
-14.4%
0.23%
-29.1%
Q3 2018$5,111,000454,2950.33%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders